Discover personalized clinical trial options designed to support your journey β safely, confidentially, and at no cost.
Takes less than 2 minutes β’ 100% confidential
Epilepsy is a neurological disorder marked by recurrent, unprovoked seizures caused by abnormal elecβ¦
Recurrent seizures, Temporary confusion, Staring spells and more.
Genetic mutations affecting ion channels or neurotransmitter receptors; Structural brain abnormalities (tumors, stroke, head injury).
Anti-Seizure Medications (ASMs), Ketogenic Diet and more.
Overview
Epilepsy is a neurological disorder marked by recurrent, unprovoked seizures caused by abnormal electrical activity in the brain. It affects around 50 million people worldwide and is one of the most common serious neurological conditions. Most people with epilepsy can achieve seizure control with medication, but about 30% have drug-resistant epilepsy and may benefit from surgery, devices, or clinical trials.
Prevalence
50M people worldwide
Worldwide statistics
Symptoms
Common Symptoms
Quality of Life Impact
Epilepsy significantly impacts daily life β driving restrictions, employment challenges, social stigma, and anxiety around seizure unpredictability are common. With good seizure control, most people lead full, active lives.
With the right care and support, most people live full, active lives.
Causes & Risk Factors
Health Insights
Active Global Trials
39+
Across all phases
Symptom Frequency
78%
Patients report primary symptom
Trial Improvement Rate
68%
Report improvement within 3 months
Avg. Trial Duration
14 mo
Median length of participation
Symptom Frequency Among Patients
Treatment
First-line treatment β levetiracetam, lamotrigine, valproate, lacosamide and 20+ others.
High-fat, low-carbohydrate diet particularly effective in drug-resistant pediatric epilepsy.
Implantable device that reduces seizure frequency by stimulating the vagus nerve.
Brain-implanted device that detects and responds to abnormal electrical activity.
Resection of the seizure focus for suitable drug-resistant candidates β seizure-free in ~60%.
Clinical Trials
UCB Pharma
Testing whether CBD added to existing seizure medications reduces seizure frequency in adults with drug-resistant focal epilepsy.
NCT05812341
Daily Life
You are not alone. Millions of people navigate Epilepsy every day β and with the right support system and treatments, a meaningful life is absolutely within reach.
Community Support
Connect with thousands of patients and caregivers
Digital Tools
Track symptoms and share insights with your care team
Specialist Network
Access to leading neurologists and researchers
Education Hub
Evidence-based resources tailored to your journey
Check Your Eligibility
Our quick eligibility check matches you with trials that fit your profile β no commitment required.
Age 18β75
Most trials are open to adults of all ages
Epilepsy diagnosis
Confirmed by a neurologist or EEG
Current medication use
Whether controlled or drug-resistant
Takes less than 2 minutes
No cost β’ No obligation β’ No spam
Why Join a Trial
Try innovative therapies before they're widely available β some with breakthrough potential.
Receive close monitoring and support from leading specialists throughout the trial.
Study-related care, tests, and the investigational treatment are provided at no charge.
Research Pipeline
Current pipeline overview for Epilepsy
Pipeline data is indicative. Source: ClinicalTrials.gov & WHO ICTRP.
Partners
Epilepsy Foundation
Patient advocacy & education
β PAG EndorsedRARE-UAE
Gulf region patient networks
β PAG EndorsedNews
FDA Approves New Anti-Seizure Medication for Treatment-Resistant Focal Epilepsy
The FDA has approved cenobamate (Xcopri) expanded indication for adults with focal onset impaired awareness seizures that have not responded to at least two prior anti-seizure medications.
FDA Β· Mar 18, 2025
FAQ
Resources
NIH MedlinePlus
Authoritative overview of Epilepsy from the National Institutes of Health.
Visit NIH β
π€Epilepsy Foundation
Patient advocacy resources, support groups, and disease education.
Visit Foundation β
π¨Emergency Guide
What to do in a Epilepsy-related emergency β share with family.
Download Guide β
βFAQ β Clinical Trials
Everything you need to know before enrolling in a clinical trial.
Read FAQ β
Your Journey Starts Here
Join thousands of patients who've found the right clinical trial through HEKMA β safely, confidentially, and at no cost.
Check Your EligibilityFDA-approved CBD medication for Dravet syndrome and Lennox-Gastaut syndrome.
